Quarterly report pursuant to Section 13 or 15(d)

Segment Disclosures

v3.8.0.1
Segment Disclosures
 9 Months Ended
Sep. 30, 2017
Segment Reporting [Abstract]  
Segment Disclosures
17.
Segment Disclosures
 
The Company has three reportable segments: Medical Devices, Industrial Sales, and Engineering Services. The Medical Devices segment designs and engineers technology for, and commercializes, manufactures, and sells exoskeletons for applications in the medical markets. The Industrial Sales segment designs, engineers, commercializes, and sells exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. Engineering Services generates revenue principally from collaborative research and development service arrangements, technology license agreements, and government grants where the Company uses its robotics domain knowledge in bionic exoskeletons to bid on and procure contracts and grants from entities such as the National Science Foundation and the Defense Advanced Research Projects Agency.
 
The Company evaluates performance and allocates resources based on segment gross profit margin. The reportable segments are each managed separately because they serve distinct markets, and one segment provides a service and the others manufacture and distribute unique products. The Company does not consider net assets as a segment measure and, accordingly, assets are not allocated.
 
Segment reporting information is as follows:
 
 
 
Device and Related
 
Engineering
 
 
 
 
 
Medical
 
Industrial
 
Total
 
Services
 
Total
 
Three months ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
1,320
 
$
267
 
$
1,587
 
$
10
 
$
1,597
 
Cost of revenue
 
 
880
 
 
165
 
 
1,045
 
 
8
 
 
1,053
 
Gross profit
 
$
440
 
$
102
 
$
542
 
$
2
 
$
544
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three months ended September 30, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
1,089
 
$
406
 
$
1,495
 
$
101
 
$
1,596
 
Cost of revenue
 
 
833
 
 
290
 
 
1,123
 
 
70
 
 
1,193
 
Gross profit
 
$
256
 
$
116
 
$
372
 
$
31
 
$
403
 
 
 
 
Device and Related
 
Engineering
 
 
 
 
 
Medical
 
Industrial
 
Total
 
Services
 
Total
 
Nine months ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
3,692
 
$
1,170
 
$
4,862
 
$
38
 
$
4,900
 
Cost of revenue
 
 
2,786
 
 
807
 
 
3,593
 
 
15
 
 
3,608
 
Gross profit
 
$
906
 
$
363
 
$
1,269
 
$
23
 
$
1,292
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nine months ended September 30, 2016
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue
 
$
10,321
 
$
682
 
$
11,003
 
$
631
 
$
11,634
 
Cost of revenue
 
 
8,543
 
 
535
 
 
9,078
 
 
452
 
 
9,530
 
Gross profit
 
$
1,778
 
$
147
 
$
1,925
 
$
179
 
$
2,104
 
 
Geographic information for revenue based on location of customers is as follows:
 
 
 
Three months ended September 30,
 
Nine months ended September 30,
 
 
 
2017
 
2016
 
2017
 
2016
 
United States
 
$
1,130
 
$
1,243
 
$
3,092
 
$
6,940
 
All Other
 
 
467
 
 
353
 
 
1,808
 
 
4,694
 
 
 
$
1,597
 
$
1,596
 
$
4,900
 
$
11,634